vs
英格索兰(IR)与Welltower(WELL)财务数据对比。点击上方公司名可切换其他公司
Welltower的季度营收约是英格索兰的1.6倍($3.4B vs $2.1B),Welltower净利率更高(22.4% vs 12.7%,领先9.7%),Welltower同比增速更快(38.3% vs 10.1%),过去两年Welltower的营收复合增速更高(55.1% vs 11.9%)
英格索兰是一家美国跨国企业,主营流体生产及工业产品业务。公司于2020年2月由原英格索兰plc的工业业务板块分拆后与加德纳丹佛合并组建,旗下拥有40多个品牌,产品覆盖全球所有主要市场。
Welltower Inc.是一家专注于医疗基础设施领域的房地产投资信托企业,核心业务为医疗类地产投资运营。截至2022年12月31日,公司投资的物业总量约3000处,全部布局于美国、加拿大及英国市场,是全球医疗地产投资领域的代表性企业之一。
IR vs WELL — 直观对比
营收规模更大
WELL
是对方的1.6倍
$2.1B
营收增速更快
WELL
高出28.2%
10.1%
净利率更高
WELL
高出9.7%
12.7%
两年增速更快
WELL
近两年复合增速
11.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $2.1B | $3.4B |
| 净利润 | $266.1M | $752.3M |
| 毛利率 | 42.6% | — |
| 营业利润率 | 18.7% | — |
| 净利率 | 12.7% | 22.4% |
| 营收同比 | 10.1% | 38.3% |
| 净利润同比 | 15.8% | 192.4% |
| 每股收益(稀释后) | $0.67 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
IR
WELL
| Q1 26 | — | $3.4B | ||
| Q4 25 | $2.1B | $2.6B | ||
| Q3 25 | $2.0B | $2.1B | ||
| Q2 25 | $1.9B | $2.0B | ||
| Q1 25 | $1.7B | $1.9B | ||
| Q4 24 | $1.9B | $1.8B | ||
| Q3 24 | $1.9B | $1.5B | ||
| Q2 24 | $1.8B | $1.4B |
净利润
IR
WELL
| Q1 26 | — | $752.3M | ||
| Q4 25 | $266.1M | $117.8M | ||
| Q3 25 | $244.1M | $282.2M | ||
| Q2 25 | $-115.3M | $304.6M | ||
| Q1 25 | $186.5M | $257.3M | ||
| Q4 24 | $229.8M | $123.8M | ||
| Q3 24 | $221.6M | $456.8M | ||
| Q2 24 | $185.0M | $260.7M |
毛利率
IR
WELL
| Q1 26 | — | — | ||
| Q4 25 | 42.6% | 24.3% | ||
| Q3 25 | 43.7% | 23.5% | ||
| Q2 25 | 43.7% | 23.2% | ||
| Q1 25 | 44.6% | 21.6% | ||
| Q4 24 | 42.9% | 20.0% | ||
| Q3 24 | 43.8% | 19.8% | ||
| Q2 24 | 43.9% | 20.2% |
营业利润率
IR
WELL
| Q1 26 | — | — | ||
| Q4 25 | 18.7% | — | ||
| Q3 25 | 19.2% | 14.2% | ||
| Q2 25 | 4.0% | 15.1% | ||
| Q1 25 | 17.6% | 10.7% | ||
| Q4 24 | 20.0% | 6.2% | ||
| Q3 24 | 19.1% | 12.2% | ||
| Q2 24 | 15.1% | 6.5% |
净利率
IR
WELL
| Q1 26 | — | 22.4% | ||
| Q4 25 | 12.7% | 4.6% | ||
| Q3 25 | 12.5% | 13.7% | ||
| Q2 25 | -6.1% | 15.5% | ||
| Q1 25 | 10.9% | 13.8% | ||
| Q4 24 | 12.1% | 7.0% | ||
| Q3 24 | 11.9% | 30.2% | ||
| Q2 24 | 10.2% | 18.7% |
每股收益(稀释后)
IR
WELL
| Q1 26 | — | — | ||
| Q4 25 | $0.67 | $0.13 | ||
| Q3 25 | $0.61 | $0.41 | ||
| Q2 25 | $-0.29 | $0.45 | ||
| Q1 25 | $0.46 | $0.40 | ||
| Q4 24 | $0.57 | $0.20 | ||
| Q3 24 | $0.54 | $0.73 | ||
| Q2 24 | $0.45 | $0.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $1.2B | $4.7B |
| 总债务越低越好 | $4.8B | — |
| 股东权益账面价值 | $10.1B | $44.7B |
| 总资产 | $18.3B | $67.2B |
| 负债/权益比越低杠杆越低 | 0.47× | — |
8季度趋势,按日历期对齐
现金及短期投资
IR
WELL
| Q1 26 | — | $4.7B | ||
| Q4 25 | $1.2B | $5.0B | ||
| Q3 25 | $1.2B | $6.8B | ||
| Q2 25 | $1.3B | $4.4B | ||
| Q1 25 | $1.6B | $3.5B | ||
| Q4 24 | $1.5B | $3.5B | ||
| Q3 24 | $1.4B | $3.6B | ||
| Q2 24 | $1.1B | $2.8B |
总债务
IR
WELL
| Q1 26 | — | — | ||
| Q4 25 | $4.8B | $19.2B | ||
| Q3 25 | $4.8B | $16.9B | ||
| Q2 25 | $4.8B | $16.0B | ||
| Q1 25 | $4.8B | $15.7B | ||
| Q4 24 | $4.8B | $15.5B | ||
| Q3 24 | $4.8B | $15.8B | ||
| Q2 24 | $4.8B | $13.9B |
股东权益
IR
WELL
| Q1 26 | — | $44.7B | ||
| Q4 25 | $10.1B | $42.1B | ||
| Q3 25 | $10.1B | $38.8B | ||
| Q2 25 | $10.1B | $35.9B | ||
| Q1 25 | $10.5B | $34.0B | ||
| Q4 24 | $10.2B | $32.0B | ||
| Q3 24 | $10.3B | $30.3B | ||
| Q2 24 | $10.0B | $29.0B |
总资产
IR
WELL
| Q1 26 | — | $67.2B | ||
| Q4 25 | $18.3B | $67.3B | ||
| Q3 25 | $18.2B | $59.5B | ||
| Q2 25 | $18.1B | $55.8B | ||
| Q1 25 | $18.4B | $53.3B | ||
| Q4 24 | $18.0B | $51.0B | ||
| Q3 24 | $18.2B | $49.0B | ||
| Q2 24 | $17.8B | $45.5B |
负债/权益比
IR
WELL
| Q1 26 | — | — | ||
| Q4 25 | 0.47× | 0.46× | ||
| Q3 25 | 0.47× | 0.43× | ||
| Q2 25 | 0.47× | 0.44× | ||
| Q1 25 | 0.45× | 0.46× | ||
| Q4 24 | 0.47× | 0.49× | ||
| Q3 24 | 0.47× | 0.52× | ||
| Q2 24 | 0.48× | 0.48× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $499.0M | — |
| 自由现金流经营现金流 - 资本支出 | $461.5M | — |
| 自由现金流率自由现金流/营收 | 22.1% | — |
| 资本支出强度资本支出/营收 | 1.8% | — |
| 现金转化率经营现金流/净利润 | 1.88× | — |
| 过去12个月自由现金流最近4个季度 | $1.2B | — |
8季度趋势,按日历期对齐
经营现金流
IR
WELL
| Q1 26 | — | — | ||
| Q4 25 | $499.0M | $654.3M | ||
| Q3 25 | $354.6M | $858.4M | ||
| Q2 25 | $245.7M | $770.0M | ||
| Q1 25 | $256.4M | $599.0M | ||
| Q4 24 | $526.2M | $559.2M | ||
| Q3 24 | $404.0M | $685.0M | ||
| Q2 24 | $304.9M | $605.4M |
自由现金流
IR
WELL
| Q1 26 | — | — | ||
| Q4 25 | $461.5M | $340.4M | ||
| Q3 25 | $325.5M | $595.3M | ||
| Q2 25 | $210.4M | $537.2M | ||
| Q1 25 | $222.7M | $358.6M | ||
| Q4 24 | $490.9M | $240.4M | ||
| Q3 24 | $374.3M | $443.8M | ||
| Q2 24 | $283.1M | $440.3M |
自由现金流率
IR
WELL
| Q1 26 | — | — | ||
| Q4 25 | 22.1% | 13.3% | ||
| Q3 25 | 16.6% | 28.9% | ||
| Q2 25 | 11.1% | 27.3% | ||
| Q1 25 | 13.0% | 19.2% | ||
| Q4 24 | 25.9% | 13.6% | ||
| Q3 24 | 20.1% | 29.4% | ||
| Q2 24 | 15.7% | 31.6% |
资本支出强度
IR
WELL
| Q1 26 | — | — | ||
| Q4 25 | 1.8% | 12.3% | ||
| Q3 25 | 1.5% | 12.8% | ||
| Q2 25 | 1.9% | 11.8% | ||
| Q1 25 | 2.0% | 12.9% | ||
| Q4 24 | 1.9% | 18.1% | ||
| Q3 24 | 1.6% | 16.0% | ||
| Q2 24 | 1.2% | 11.8% |
现金转化率
IR
WELL
| Q1 26 | — | — | ||
| Q4 25 | 1.88× | 5.56× | ||
| Q3 25 | 1.45× | 3.04× | ||
| Q2 25 | — | 2.53× | ||
| Q1 25 | 1.37× | 2.33× | ||
| Q4 24 | 2.29× | 4.52× | ||
| Q3 24 | 1.82× | 1.50× | ||
| Q2 24 | 1.65× | 2.32× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IR
| Transferred At Point In Time | $1.5B | 71% |
| Transferred Over Time | $193.0M | 9% |
| Precision And Science Technologies Segment | $183.1M | 9% |
| Acquisitions In2024 | $175.6M | 8% |
| Acquisitions In2025 | $70.8M | 3% |
WELL
| Resident fees and services | $2.8B | 83% |
| Rental income | $453.8M | 14% |
| Other | $117.2M | 3% |